Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 691 of 1,261
  1. US 9351490

    Selectively targeted antimicrobial peptides and the use thereof

    The Regents of the University of California · Granted May 31, 2016 · Expires May 26, 2036

    granted
  2. US 9351954

    Multicyclic compounds and methods of use thereof

    PGI Drug Discovery LLC · Granted May 31, 2016 · Expires May 26, 2036

    granted
  3. US 9351962

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2016 · Expires May 26, 2036

    granted
  4. US 9351964

    Methods for treating cancer and non-neoplastic conditions

    PTC THERAPEUTICS, INC. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  5. US 9353240

    Elastomer formulations comprising discrete carbon nanotube fibers

    MOLECULAR REBAR DESIGN, LLC · Granted May 31, 2016 · Expires May 26, 2036

    granted
  6. US 9353178

    Stem cell factor inhibitor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 31, 2016 · Expires May 26, 2036

    granted
  7. US 9353353

    Virus-like particles (VLPs) prepared from chikungunya virus structural proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 31, 2016 · Expires May 26, 2036

    granted
  8. US 9353352

    Embryonic stem cell specific microRNAs promote induced pluripotency

    The Regents of the University of California · Granted May 31, 2016 · Expires May 26, 2036

    granted
  9. US 9353163

    Apelin fusion proteins and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  10. US 9353126

    Substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  11. US 9353117

    Substituted pyrazolopyrimidines as glucocerebrosidase activators

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted May 31, 2016 · Expires May 26, 2036

    granted
  12. US 9353111

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  13. US 9353175

    Use of antagonists targeting metallothionein to treat intestinal inflammation

    UNIVERSITY OF CONNECTICUT · Granted May 31, 2016 · Expires May 26, 2036

    granted
  14. US 9353107

    3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors

    Aurigene Discovery Technologies Limited · Granted May 31, 2016 · Expires May 26, 2036

    granted
  15. US 9353094

    Substituted quinoxalines as kinase inhibitors

    The Board of Regents of the University of Texas System · Granted May 31, 2016 · Expires May 26, 2036

    granted
  16. US 9353108

    Tetrahydronaphthyridine somatostatin receptor 5 antagonists

    Takeda Pharmaceutical Company Limited · Granted May 31, 2016 · Expires May 26, 2036

    granted
  17. US 9353069

    Super-oxide dismutase mimetics

    Galera Labs, LLC · Granted May 31, 2016 · Expires May 26, 2036

    granted
  18. US 9353106

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted May 31, 2016 · Expires May 26, 2036

    granted
  19. US 9352027

    Albumin-free factor VIII formulations

    UNIVERSITY OF CONNECTICUT · Granted May 31, 2016 · Expires May 26, 2036

    granted
  20. US 9352019

    Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

    University of Connecticut Health Center · Granted May 31, 2016 · Expires May 26, 2036

    granted
  21. US 9352032

    Live attenuated antigenically marked classical swine fever vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted May 31, 2016 · Expires May 26, 2036

    granted
  22. US 9352048

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  23. US 9352011

    Method and composition for synchronizing time of insemination

    JBS United Animal Health II LLC · Granted May 31, 2016 · Expires May 26, 2036

    granted
  24. US 9351984

    Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity

    The Board of Regents of the University of Texas System · Granted May 31, 2016 · Expires May 26, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.